Clinical Trial Update: Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating topical minocycline for suppression of cutaneous allergic responses and pruritus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Minocycline (topical) (minocycline)

Snippet

Sponsor: State University of New York - Downstate Medical Center | Conditions: Allergic Rhinitis, Asthma | Phase 2 | Status: UNKNOWN